The integumentary system is the body's largest organ system, encompassing the skin, hair, nails, and associated glands. Its primary function is to protect the body from external factors such as pathogens, UV radiation, and physical injury, while also helping to regulate temperature and maintain hydration.
The skin, consisting of the epidermis, dermis, and subcutaneous tissue, acts as a barrier against harmful substances and prevents excessive water loss. It also contains sensory receptors that detect stimuli like touch, pressure, temperature, and pain. Hair and nails, derived from specialized skin cells, provide additional protection and sensory functions.
Furthermore, the integumentary system includes various glands such as sweat glands, sebaceous glands, and mammary glands, which secrete substances like sweat, oil, and milk, respectively. These secretions play roles in temperature regulation, lubrication, and antimicrobial defense.
Overall, the integumentary system is crucial for maintaining homeostasis, protecting the body's internal environment, and facilitating sensory experiences essential for survival and interaction with the external world.
Several major disorders can affect the integumentary system, ranging from relatively common conditions to more severe diseases:
These disorders can vary in severity and require different treatment approaches, including medications, topical treatments, lifestyle modifications, and sometimes surgical intervention. Regular skincare practices and sun protection are essential for preventing some integumentary disorders.
Hyperinsulinemia, insulin resistance, and metabolic syndrome are all interconnected conditions that can contribute to various disorders of the integumentary system through several mechanisms:
Overall, the dysregulation of insulin and metabolic processes seen in hyperinsulinemia, insulin resistance, and metabolic syndrome can contribute to the development and exacerbation of various integumentary disorders through multiple pathways. Disorders of the integumentary system can affect these structures and may manifest as various skin conditions.
Several integumentary disorders are closely associated with insulin resistance, hyperinsulinemia, or metabolic syndrome:
These integumentary disorders underscore the systemic nature of insulin resistance, hyperinsulinemia, and metabolic syndrome, emphasizing the importance of comprehensive management strategies targeting both metabolic and dermatological aspects of these conditions.
Excessive adiposity can lead to stretch marks, skin tags, and increased sweating due to enlarged fat cells and hormonal changes.
iabetes can cause diabetic dermopathy, skin infections, and slow wound healing due to impaired blood flow and nerve damage.
Acne is a common skin condition characterized by the presence of pimples, blackheads, whiteheads, and inflamed lesions on the skin, typically occurring on the face, neck, chest, and back. While hyperinsulinemia, characterized by elevated levels of insulin in the blood, is not a direct cause of acne, it may contribute to its development and exacerbation through several mechanisms. Insulin resistance, a hallmark of hyperinsulinemia and metabolic syndrome, is associated with elevated levels of insulin and insulin-like growth factor 1 (IGF-1), which can stimulate the production of androgens (male hormones) in the body. Androgens play a role in increasing sebum (oil) production and promoting the proliferation of skin cells, which can contribute to the formation of acne lesions. Additionally, hyperinsulinemia may promote inflammation and oxidative stress, further exacerbating acne symptoms. Furthermore, insulin resistance can lead to fluctuations in blood sugar levels, which may trigger hormonal imbalances and skin inflammation, potentially worsening acne. Therefore, managing hyperinsulinemia through lifestyle modifications, insulin-sensitizing medications, and appropriate skincare practices may help improve acne symptoms. Additionally, individuals with acne should work closely with dermatologists to develop personalized treatment plans targeting the underlying causes and symptoms of their condition.
Acanthosis nigricans is a skin condition characterized by dark, velvety patches of skin, often found in body folds and creases such as the neck, armpits, groin, and sometimes on the elbows, knees, and knuckles. While not directly caused by hyperinsulinemia, acanthosis nigricans is commonly associated with insulin resistance and conditions such as obesity, type 2 diabetes, and metabolic syndrome. Insulin resistance leads to increased insulin levels, which can stimulate the growth of skin cells and the production of pigment, resulting in the characteristic darkening and thickening of the skin. Managing insulin resistance through lifestyle changes, weight loss, and treatment of underlying conditions can help improve acanthosis nigricans. Additionally, addressing any hormonal imbalances or other contributing factors may also be beneficial. It's important for individuals with acanthosis nigricans to consult with healthcare professionals for proper diagnosis and management.
The prevalence of obesity has increased worldwide in recent years. Some authors have described skin conditions associated with obesity, but there is little evidence on the association between insulin levels and such disorders.
To describe the skin disorders present in overweight and obese patients and analyze their association with insulin levels.
The study included nondiabetic male and female patients over 6 years of age who were seen at our hospital between January and April 2011. All the patients were evaluated by a dermatologist, who performed a physical examination, including anthropometry, and reviewed their medical history and medication record; fasting blood glucose and insulin were also measured. The patients were grouped according to degree of overweight or obesity and the data were compared using analysis of variance or the χ2 test depending on the type of variable. The independence of the associations was assessed using regression analysis.
In total, 109 patients (95 adults and 13 children, 83.5% female) were studied. The mean (SD) age was 38 (14) years and the mean body mass index was 39.6 ± 8 kg/m2. The skin conditions observed were acanthosis nigricans (AN) (in 97% of patients), skin tags (77%), keratosis pilaris (42%), and plantar hyperkeratosis (38%). Statistically significant associations were found between degree of obesity and AN (P = .003), skin tags (P = .001), and plantar hyperkeratosis. Number of skin tags, AN neck severity score, and AN distribution were significantly and independently associated with insulin levels.
AN and skin tags should be considered clinical markers of hyperinsulinemia in nondiabetic, obese patients.
Acrochordons, commonly known as skin tags, are small, benign growths that typically appear as soft, hanging pieces of skin. While the exact cause of acrochordons is not fully understood, they are often associated with friction or rubbing of the skin, such as in areas where skin folds or creases occur. Additionally, acrochordons may be more common in individuals with certain conditions such as obesity, insulin resistance, and metabolic syndrome. Although hyperinsulinemia itself isn't a direct cause of acrochordons, it is often associated with insulin resistance, which may play a role in their development. Insulin resistance can lead to changes in skin structure and metabolism, possibly contributing to the formation of acrochordons. While acrochordons are typically harmless and may not require treatment, they can be removed if they cause discomfort or cosmetic concerns. It's essential for individuals with acrochordons to consult with healthcare professionals for proper evaluation and management.
described skin conditions associated with obesity, but there is little evidence on the association between insulin levels and such disorders.
To describe the skin disorders present in overweight and obese patients and analyze their association with insulin levels.
The study included nondiabetic male and female patients over 6 years of age who were seen at our hospital between January and April 2011. All the patients were evaluated by a dermatologist, who performed a physical examination, including anthropometry, and reviewed their medical history and medication record; fasting blood glucose and insulin were also measured. The patients were grouped according to degree of overweight or obesity and the data were compared using analysis of variance or the χ2 test depending on the type of variable. The independence of the associations was assessed using regression analysis.
In total, 109 patients (95 adults and 13 children, 83.5% female) were studied. The mean (SD) age was 38 (14) years and the mean body mass index was 39.6 ± 8 kg/m2. The skin conditions observed were acanthosis nigricans (AN) (in 97% of patients), skin tags (77%), keratosis pilaris (42%), and plantar hyperkeratosis (38%). Statistically significant associations were found between degree of obesity and AN (P = .003), skin tags (P = .001), and plantar hyperkeratosis. Number of skin tags, AN neck severity score, and AN distribution were significantly and independently associated with insulin levels.
AN and skin tags should be considered clinical markers of hyperinsulinemia in nondiabetic, obese patients.
Androgenetic alopecia, also known as male or female pattern baldness, is a common form of hair loss that occurs due to a combination of genetic, hormonal, and environmental factors. While hyperinsulinemia isn't a direct cause of androgenetic alopecia, it may play a role in its development or progression. Hyperinsulinemia, often associated with insulin resistance and metabolic syndrome, can lead to increased levels of insulin and insulin-like growth factor 1 (IGF-1), which may stimulate the production of androgens (male hormones) in the body. Androgens, particularly dihydrotestosterone (DHT), are known to play a role in shrinking hair follicles and shortening the hair growth cycle, ultimately leading to hair thinning and eventual hair loss in susceptible individuals. Additionally, insulin resistance is associated with chronic low-grade inflammation, which may contribute to hair follicle miniaturization and the progression of androgenetic alopecia. Managing hyperinsulinemia through lifestyle modifications, such as weight loss, dietary changes, and insulin-sensitizing medications, may help slow down the progression of androgenetic alopecia. Additionally, individuals with androgenetic alopecia should work closely with healthcare professionals to explore treatment options and strategies to preserve existing hair and promote hair regrowth.
Cutaneous candidiasis is a fungal infection of the skin caused by Candida species, typically Candida albicans. While hyperinsulinemia isn't a direct cause of cutaneous candidiasis, it may contribute to its development or exacerbation. Hyperinsulinemia, often associated with insulin resistance and obesity, can lead to elevated levels of insulin and glucose in the blood, creating an environment conducive to fungal growth. Additionally, insulin resistance is associated with impaired immune function and chronic low-grade inflammation, which may further compromise the body's ability to fight off fungal infections. Furthermore, warm and moist skin folds, such as those found in the groin, armpits, and under the breasts, provide an ideal breeding ground for Candida fungi, increasing the likelihood of infection in individuals with hyperinsulinemia. Managing hyperinsulinemia through lifestyle modifications, such as weight loss, dietary changes, and insulin-sensitizing medications, may help reduce the risk of cutaneous candidiasis. Additionally, individuals with cutaneous candidiasis should work closely with healthcare professionals to receive appropriate antifungal treatment and prevent recurrent infections.
Hidradenitis suppurativa (HS) is a chronic, inflammatory disease of the pilosebaceous unit. Patients with HS present – often after a diagnostic delay – with multiple, recurrent inflammatory nodules, abscesses and sinus tracts in intertriginous skin.1 Data suggest that the prevalence of HS varies between 0.14% and 4% globally (Table 1).
Malta is a small Mediterranean country with an estimated population of 493 559 inhabitants.2 The country is in a unique position as all dermatology referrals made in the national healthcare system are received and pooled by a single dermatology centre (Sir Paul Boffa Hospital, SPBH) and distributed equally between dermatologists without bias. Follow‐up care is also carried out at SPBH. We carried out a study to establish the prevalence of HS in Malta.
Between 1 January 2019 and 31 December 2019, a single dermatologist (Dillon MIntoff) working at SPBH reviewed 2034 patients referred for a dermatological opinion. Patients not residing in Malta and patients who were referred directly to the auditing dermatologist with an established or suspected diagnosis of HS were excluded from the study to avoid bias.
Hidradenitis suppurativa (HS) is a chronic skin condition characterized by the development of painful, inflamed lesions, typically in areas where skin rubs together, such as the armpits, groin, buttocks, and under the breasts. While the exact cause of HS is not fully understood, it is believed to involve a combination of genetic, hormonal, and environmental factors. While hyperinsulinemia isn't a direct cause of HS, it may contribute to its development or exacerbation. Hyperinsulinemia, often associated with insulin resistance and obesity, can lead to increased levels of insulin and insulin-like growth factor 1 (IGF-1), which may stimulate inflammation and abnormal skin cell growth. Additionally, insulin resistance is associated with chronic low-grade inflammation, which may further contribute to the inflammatory process in HS. Managing hyperinsulinemia through lifestyle modifications, such as weight loss, dietary changes, and insulin-sensitizing medications, may help improve symptoms and reduce the severity of HS. Additionally, individuals with HS should work closely with healthcare professionals to develop a personalized treatment plan that addresses their specific needs and symptoms.
" Hidradenitis suppurativa is a chronic, inflammatory, recurrent, debilitating skin disease characterized by recurrent abscesses, draining sinuses, and scarring, affecting principally areas of body friction "
"Hidradenitis suppurativa (HS) is a chronic-relapsing inflammatory skin disease. It usually appears in the second and third decades, but a smaller proportion of patients develop late-onset HS . Hidradenitis suppurativa (HS) is associated with comorbidities that contribute to poor health, impaired life quality, and mortality risk. HS is associated with Acne, dissecting cellulitis of the scalp, pilonidal disease, pyoderma gangrenosum, depression, generalized anxiety disorder, suicide, smoking, substance use disorder, polycystic ovary syndrome, obesity, dyslipidemia, diabetes mellitus, metabolic syndrome, hypertension, cardiovascular disease, inflammatory bowel disease, spondyloarthritis, and sexual dysfunction. "
"There are associations between HS and other cardiovascular disease (CVD) risk factors, including type 2 diabetes and metabolic syndrome. People with HS have double the risk of death from CVD compared with those without HS and 1·5 times the risk compared with patients with psoriasis. Depression and anxiety are associated with HS and completed suicide rates in those with HS are more than double the rates in controls. Associations exist between HS and other chronic inflammatory conditions, particularly inflammatory bowel disease and inflammatory arthritis. Case-control studies demonstrate associations with pilonidal sinus, polycystic ovary syndrome, Down syndrome, obstructive sleep apnoea and pyoderma gangrenosum. "
Hidradenitis suppurativa (HS) often coexists with obesity, metabolic syndrome, diabetes mellitus, or impaired glucose tolerance and insulin resistance and polycystic ovarian syndrome.
"Four studies (106 patients) documented improvement, 1 documented treatment failure, and 1 had mixed results. Only mild and transient side effects were noted. Metformin has been tried in few HS patients with acceptable efficacy in a fair number of them"
" The association of the metabolic syndrome (MetS) and its components with immune-mediated chronic inflammatory disorders has attracted much interest within the last two decades. In addition to the well-established association of psoriasis with MetS, recent data point to an association between MetS and hidradenitis suppurativa, as well. The association of hidradenitis suppurativa with MetS and its components, such as diabetes, obesity, and dyslipidemia, has been consistently identified in controlled studies. This relationship is not only limited to older individuals but also applicable to younger patients and those with mild disease. "
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Mitochondria play a crucial role in maintaining the health and functionality of the integumentary system, which includes the skin, hair, and nails. Within the cells of the skin, mitochondria are responsible for producing the energy necessary to support various cellular processes, including cell growth, repair, and regeneration. Additionally, mitochondria play a role in regulating oxidative stress and cellular signaling pathways within the skin cells, which are essential for maintaining skin health and integrity. Dysfunction of mitochondria within skin cells can lead to impaired energy production, oxidative damage, and cellular dysfunction, contributing to skin conditions such as premature aging, wrinkles, and impaired wound healing. Moreover, mitochondria are involved in regulating apoptosis (programmed cell death) in skin cells, which is essential for removing damaged cells and maintaining the overall health of the skin. Furthermore, mitochondria contribute to the production of melanin, the pigment responsible for skin color, through a process called melanogenesis. Dysfunction in mitochondrial activity within melanocytes, the cells responsible for producing melanin, can lead to pigment disorders such as hyperpigmentation or hypopigmentation. In summary, mitochondria are indispensable for the proper functioning of the integumentary system. Their role in energy production, cellular signaling, and melanin synthesis highlights their importance in maintaining skin health, hair growth, and nail integrity. Understanding the intricate relationship between mitochondria and the integumentary system is crucial for developing effective strategies for preventing and treating skin conditions and promoting overall skin health. Similar to other body systems, nutrient-dense foods support optimal mitochondrial function in the integumentary system. Whole foods rich in antioxidants, vitamins, minerals, and phytonutrients promote skin health by providing essential nutrients necessary for mitochondrial energy production and cellular function. In contrast, processed foods high in added sugars, unhealthy fats, and preservatives lack these beneficial nutrients and may contribute to oxidative stress, inflammation, and mitochondrial dysfunction in skin cells. When mitochondria are damaged due to poor dietary choices, several detrimental effects can occur within the integumentary system. Impaired mitochondrial function can lead to decreased energy production, oxidative damage, and impaired wound healing in the skin. Additionally, dysfunctional mitochondria can contribute to pigment disorders and premature aging of the skin. Therefore, prioritizing a diet rich in nutrient-dense whole foods and minimizing the consumption of processed foods is essential for supporting mitochondrial function, maintaining skin health, and promoting overall well-being. By nourishing the integumentary system with essential nutrients, individuals can help preserve mitochondrial health and reduce the risk of skin conditions, highlighting the critical role of diet in supporting skin function and health.
Psoriasis is a chronic autoimmune skin condition characterized by the rapid overproduction of skin cells, leading to the formation of thick, red, scaly patches on the skin. It is a non-contagious condition that affects about 2-3% of the global population.
The exact cause of psoriasis is not fully understood, but it is believed to involve a combination of genetic, environmental, and immune system factors. In people with psoriasis, the immune system mistakenly attacks healthy skin cells, causing them to proliferate rapidly. This results in the formation of plaques, which can appear anywhere on the body but are most commonly found on the elbows, knees, scalp, and lower back.
Psoriasis can vary in severity, with some individuals experiencing only mild symptoms and others experiencing more severe symptoms that significantly impact their quality of life. In addition to the physical symptoms, psoriasis can also have psychological and emotional effects, including feelings of self-consciousness, embarrassment, and depression.
Common types of psoriasis include:
Treatment for psoriasis aims to reduce inflammation, slow down the growth of skin cells, and alleviate symptoms. This may include topical treatments (such as corticosteroids, vitamin D analogs, and retinoids), phototherapy (exposure to ultraviolet light), oral medications (such as methotrexate, cyclosporine, and biologics), and lifestyle modifications (such as stress management, avoiding triggers, and maintaining a healthy lifestyle). While there is no cure for psoriasis, treatment can help control symptoms and improve quality of life for individuals with the condition
"For anyone who suffers from an inflammatory (even autoimmune) disease, a ketogenic diet should be considered. Mounting evidence reveals a direct effect of ketones inhibiting inflammation. This study explored two psoriasis conditions [skin (PSO) and joint (PSA); autoimmune related] and compared the effects of a Mediterranean and Ketogenicc Diet and concluded "...the combined 22-week MD–KD program for patients with PSO and PSA on stable anti-psoriatic pharmacological treatment led to weight loss and enhancements in clinical and biochemical markers of inflammation. However, these favorable effects were mainly attributed to KD, as statistically significant reductions in clinical scores of disease activity and inflammatory markers were observed only in this dietary regimen." Ben Bikamn
" The effect of different diet patterns on psoriasis (PSO) and psoriatic arthritis (PSA) is unknown. Τhe aim of our study was to evaluate the effectiveness of a Mediterranean diet (MD) and Ketogenic diet (KD), in patients with PSO and PSA. Twenty-six patients were randomly assigned to start either with MD or KD for a period of 8 weeks. After a 6-week washout interval, the two groups were crossed over to the other type of diet for 8 weeks. At the end of this study, MD and KD resulted in significant reduction in weight (p = 0.002, p < 0.001, respectively), in BMI (p = 0.006, p < 0.001, respectively), in waist circumference (WC) (p = 0.001, p < 0.001, respectively), in total fat mass (p = 0.007, p < 0.001, respectively), and in visceral fat (p = 0.01, p < 0.001, respectively), in comparison with baseline. After KD, patients displayed a significant reduction in the Psoriasis Area and Severity Index (PASI) (p = 0.04), Disease Activity Index of Psoriatic Arthritis (DAPSA) (p = 0.004), interleukin (IL)-6 (p = 0.047), IL-17 (p = 0.042), and IL-23 (p = 0.037), whereas no significant differences were observed in these markers after MD (p > 0.05), compared to baseline. The 22-week MD–KD diet program in patients with PSO and PSA led to beneficial results in markers of inflammation and disease activity, which were mainly attributed to KD."
Striae, commonly known as stretch marks, are thin, linear streaks or bands that develop on the skin when it is stretched rapidly, causing the collagen and elastin fibers in the dermis to break or tear. While hyperinsulinemia isn't a direct cause of striae, it may contribute to their development or exacerbation. Hyperinsulinemia, often associated with insulin resistance and obesity, can lead to increased levels of insulin and insulin-like growth factor 1 (IGF-1), which may affect the skin's elasticity and repair processes. Additionally, insulin resistance is associated with chronic low-grade inflammation, which may impair the skin's ability to heal and regenerate. Furthermore, rapid weight gain or fluctuations in body size, often seen in individuals with hyperinsulinemia, can further stretch the skin and increase the likelihood of developing striae. Managing hyperinsulinemia through lifestyle modifications, such as weight management and insulin-sensitizing medications, may help reduce the risk of striae formation. Additionally, topical treatments and procedures such as laser therapy may help improve the appearance of existing striae. It's important for individuals with striae to consult with healthcare professionals for proper evaluation and management.
Trace element deficiencies refer to inadequate levels of essential minerals required by the body in small amounts for proper functioning. While hyperinsulinemia isn't directly linked to trace element deficiencies, it may indirectly impact their absorption, utilization, or excretion in the body. Insulin resistance, a hallmark of hyperinsulinemia and metabolic syndrome, can disrupt various metabolic processes, including those involved in the regulation of trace elements. For example, insulin resistance may affect the transport of trace elements across cell membranes or interfere with their uptake by tissues. Additionally, hyperinsulinemia may alter the balance of certain hormones or metabolic pathways involved in trace element metabolism. Consequently, individuals with hyperinsulinemia may be at increased risk of developing trace element deficiencies, particularly if they have poor dietary habits or other underlying health conditions. Managing hyperinsulinemia through lifestyle modifications, such as improving dietary quality and insulin sensitivity, may help prevent or alleviate trace element deficiencies. Additionally, supplementation with specific trace elements may be necessary in some cases to correct deficiencies and support overall health and well-being. It's important for individuals with hyperinsulinemia to work closely with healthcare professionals to address any nutritional deficiencies and optimize their nutrient intake.
" The analysis of serum glucose concentration failed to reveal any group difference in serum glucose in the studied sample of obese patients, whereas serum insulin levels were found to be 40% higher. Correspondingly, 48% higher HOMA-IR values in obese examinees are indicative of insulin resistance without manifest hyperglycemia. "
"Obese subjects were characterized by significantly higher body fat percentage, blood pressure, serum triglyceride concentration, and insulin resistance. Serum Ca, Fe, Mg, Se, V, Zn levels, hair Fe, Mg, V content, and urinary Se and V concentrations were found to be lower in obese subjects as compared to lean controls. In turn, serum Cu and urinary Fe levels in obese women were characterized by a significant increase. "
( Your body needs small amounts of copper (serum CU) from food to stay healthy. But a buildup of too much copper is serious. At the extreme It can result in brain damage, liver failure, or death if it is not treated. )
Plantar keratosis refers to a dermatological condition characterized by the thickening of the skin on the soles of the feet (the plantar surface). This thickening is often due to excessive pressure or friction on specific areas of the feet, leading to the accumulation of hardened skin or calluses.
Plantar keratosis typically presents as yellowish or brownish patches of rough, thickened skin on weight-bearing areas of the feet, such as the heels or balls of the feet. It may be asymptomatic or associated with discomfort, pain, or tenderness, especially when standing or walking.
Causes of plantar keratosis may include wearing ill-fitting shoes, excessive standing or walking, abnormal foot mechanics (such as flat feet or high arches), obesity, or certain foot deformities.
It is associated with Obesity
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Copyright © 2024 Metabolic Health Malta - All Rights Reserved.
metabolichealthmalta.com
disclaimer The views and opinions expressed on this site are solely those of the contributing individuals and authors, and in no way reflect or represent the position of the authors' employers, management, shareholders or other employees thereof. All data and information provided on this site is for informational purposes only. We make no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis.
We do not provide medical advice. All individuals should seek personal medical assistance in considering adopting any personal diet. No responsibility can be taken for any actions taken by anyone including health professionals, social media or personal health.
Powered by GoDaddy